Seno Medical’s Breast Imaging System Receives FDA Premarket Approval
Seno's Imagio Breast Imaging System received supplemental premarket approval from the Center for Devices and Radiological Health of the FDA.
Seno's Imagio Breast Imaging System received supplemental premarket approval from the Center for Devices and Radiological Health of the FDA.
A new nuclear imaging technique may help identify women at increased risk of heart damage due to their cancer treatment. The University of Ottawa Heart Institute and The Ottawa Hospital have recently launched a clinical trial to assess the use of the novel test in breast cancer patients undergoing chemotherapy.
Seno's Imagio Breast Imaging System received supplemental premarket approval from the Center for Devices and Radiological Health of the FDA.